CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world’s premier diabetic foot conference (DFCon) in Los Angeles
![CellResearch Corporation Logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/09/CellResearch_Corporation_Logo-1024x512.jpg)
LOS ANGELES, Sept. 26, 2022 /PRNewswire/ — CRC is delighted to announce attendance at DFCon, the global specialist multidisciplinary congress focused on the diabetic foot held in late September 2022 in Los Angeles, USA. The meeting is a gathering of a wide range of both generalists and specialists who diagnose and manage diabetic feet, to […]